Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

FDA Approval
Medtronic Launching New Frontier in Treating High Blood Pressure With FDA Approval of Symplicity Spyral Renal Denervation System
11/20/2023

Medtronic News

Medtronic News
Manufacturing of the device for U.S. distribution is already underway, and Medtronic hopes to make it widely available soon to physicians and healthcare systems.
Manufacturing of the device for U.S. distribution is already underway, and Medtronic hopes to make it widely available soon to physicians and healthcare systems.
Manufacturing of the device for...
11/20/2023
Cath Lab Digest
News
Medtronic Receives CE Mark Approval for Innovative Technologies in Pulsed Field and Cryoablation: PulseSelect™ Pulsed Field Ablation System and Nitron CryoConsole™ to Advance Treatment of Atrial Fibrillation
11/20/2023

Medtronic Press Release 

Medtronic Press Release 
Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation
Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation
Simplicity, efficiency, efficacy...
11/20/2023
EP Lab Digest
News
Element Science Announces Presentation of Successful Results of the Jewel® IDE Study in a Featured Science Presentation at the American Heart Association’s 2023 Annual Scientific Sessions
11/14/2023

Element Science Press Release 

Element Science Press Release  ...
Strongly positive findings demonstrate the life-saving potential of the Jewel® Patch Wearable Cardioverter Defibrillator for patients at elevated risk of sudden cardiac arrest.
Strongly positive findings demonstrate the life-saving potential of the Jewel® Patch Wearable Cardioverter Defibrillator for patients at elevated risk of sudden cardiac arrest.
Strongly positive findings...
11/14/2023
EP Lab Digest

Advertisement

News
Oral Presentation at American Heart Association’s Scientific Sessions Highlights the Need for Esophageal Protection During Ablation
11/14/2023

 Attune Medical Press Release 

 Attune Medical Press Release  ...
CHICAGO -- An oral presentation at the American Heart Association’s Scientific Sessions examined recent reporting rates of esophageal injury after left atrial ablation for the treatment of atrial fibrillation and found that the rates have not...
CHICAGO -- An oral presentation at the American Heart Association’s Scientific Sessions examined recent reporting rates of esophageal injury after left atrial ablation for the treatment of atrial fibrillation and found that the rates have not...
CHICAGO -- An oral presentation...
11/14/2023
EP Lab Digest
News
Anthos Therapeutics' Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation
11/14/2023

Anthos Therapeutics Press Release 

Anthos Therapeutics Press Release  ...
Secondary Endpoints Also Showed a Highly Significant 74% Reduction in Major Bleeding and a 93% Reduction in Gastrointestinal (GI) Bleeding with Abelacimab These Results Triggered the Data Monitoring Committee (DMC) to Stop the AZALEA-TIMI...
Secondary Endpoints Also Showed a Highly Significant 74% Reduction in Major Bleeding and a 93% Reduction in Gastrointestinal (GI) Bleeding with Abelacimab These Results Triggered the Data Monitoring Committee (DMC) to Stop the AZALEA-TIMI...
Secondary Endpoints Also Showed...
11/14/2023
EP Lab Digest
News
Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023
11/14/2023

Milestone Pharmaceuticals Inc. Press Release 

Milestone Pharmaceuticals Inc. Press ...
  Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p < 0.0001) compared to...
  Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p < 0.0001) compared to...
  Etripamil, an...
11/14/2023
EP Lab Digest

Advertisement

News
Exciting New Applications of vMap for Ventricular Arrhythmias Highlighted at AHA 2023
11/14/2023

Vektor Medical Press Release 

Vektor Medical Press Release 
Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias
Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias
Research presented at AHA...
11/14/2023
EP Lab Digest
News
New Asundexian Phase III Study to Include Patients With Atrial Fibrillation Ineligible for Oral Anticoagulant Treatment
11/14/2023

Bayer Press Release 

Bayer Press Release 
New study includes patients aged ≥65 years with atrial fibrillation (AF) at high risk for ischemic stroke or systemic embolism who are deemed ineligible for oral anticoagulant (OAC) treatment due to increased risk of...
New study includes patients aged ≥65 years with atrial fibrillation (AF) at high risk for ischemic stroke or systemic embolism who are deemed ineligible for oral anticoagulant (OAC) treatment due to increased risk of...
New study includes patients...
11/14/2023
EP Lab Digest
News
AHA's Risk Calculator, PREVENT (Predicting Risk of cardiovascular disease EVENTs), Estimates Heart Attack, Stroke and Heart Failure Risk
11/13/2023

American Heart Association News

American Heart Association News ...
The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex. As more research has been conducted specifically in women, this is an important way to understand their unique differences in CVD presentation and risk...
The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex. As more research has been conducted specifically in women, this is an important way to understand their unique differences in CVD presentation and risk...
The PREVENT risk calculator...
11/13/2023
Cath Lab Digest

Advertisement

News
New Data Demonstrates Medtronic LINQ II Insertable Cardiac Monitors and AccuRhythm AI Algorithm Further Reduce False Alerts
11/13/2023

Medtronic Press Release 

Medtronic Press Release 
AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year
AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year
AHA23: Artificial intelligence...
11/13/2023
EP Lab Digest

Advertisement

EPLD August 2024 cover.

Current Issue

August 2024
Volume 24
Issue 8
Current Issue
Issue Archive

Advertisement

Advertisement

Stay in the know.

EP Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Ahead of Print

Clinical Images
Redo Transcatheter Aortic Valve Replacement in a Young Patient With Congenital Aortic Valve Disease
08/07/2024
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone...
08/07/2024
Journal of Invasive Cardiology
Clinical Images
Redo Transcatheter Aortic Valve Replacement in a Young Patient With Congenital Aortic Valve Disease
08/07/2024
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone complex presented with acute decompensated heart failure. He had undergone 4 previous sternotomies and a 23-mm Sapien XT transcatheter aortic valve replacement for severe bioprosthetic aortic regurgitation in 2014.
A 39-year-old man with Shone...
08/07/2024
Journal of Invasive Cardiology
Clinical Images
Stentectomy by an Entrapped Rotational Atherectomy Burr
08/05/2024
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with...
08/05/2024
Journal of Invasive Cardiology
Clinical Images
Stentectomy by an Entrapped Rotational Atherectomy Burr
08/05/2024
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with exertional angina and anterior ischemia on stress testing. He had undergone prior coronary artery bypass surgery and multiple percutaneous coronary interventions.
A 73-year-old man presented with...
08/05/2024
Journal of Invasive Cardiology
Clinical Images
Calcium Is Not an Issue for Transcatheter Therapy in the Mitral Valve: The Role of Independent Leaflet Grasping
07/30/2024
A 75-year-old woman with a history of heart failure was referred for dyspnea upon exertion due to severe mitral regurgitation.
A 75-year-old woman with a history of heart failure was referred for dyspnea upon exertion due to severe mitral regurgitation.
A 75-year-old woman with a...
07/30/2024
Journal of Invasive Cardiology

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use